4.6 Article

Sonic hedgehog signaling instigates high-fat diet-induced insulin resistance by targeting PPAR stability

期刊

JOURNAL OF BIOLOGICAL CHEMISTRY
卷 294, 期 9, 页码 3284-3293

出版社

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.RA118.004411

关键词

sonic hedgehog (SHH); peroxisome proliferator-activated receptor (PPAR); protein degradation; ubiquitylation (ubiquitination); obesity; insulin resistance; type 2 diabetes; NEDD4-1

资金

  1. National Science Foundation of China [81830015, 81500345, 31430045, 81470373, 81600389, 81770497, 2015M582674, 2016T90928]
  2. China Postdoctoral Science Foundation

向作者/读者索取更多资源

Obesity is a major risk for patients with chronic metabolic disorders including type 2 diabetes. Sonic hedgehog (Shh) is a morphogen that regulates the pancreas and adipose tissue formation during embryonic development. Peroxisome proliferator-activated receptor (PPAR) is a member of the nuclear receptor superfamily and one of the most important regulators of insulin action. Here, we evaluated the role and mechanism of Shh signaling in obesity-associated insulin resistance and characterized its effect on PPAR. We showed that Shh expression was up-regulated in subcutaneous fat from obese mice. In differentiated 3T3-L1 and primary cultured adipocytes from rats, recombinant Shh protein and SAG (an agonist of Shh signaling) activated an extracellular signal-regulated kinase (ERK)-dependent noncanonical pathway and induced PPAR phosphorylation at serine 112, which decreased PPAR activity. Meanwhile, Shh signaling degraded PPAR protein via binding of PPAR to neural precursor cell-expressed developmentally down-regulated protein 4-1 (NEDD4-1). Furthermore, vismodegib, an inhibitor of Shh signaling, attenuated ERK phosphorylation induced by a high fat diet (HFD) and restored PPAR protein level, thus ameliorating glucose intolerance and insulin resistance in obese mice. Our finding suggests that Shh in subcutaneous fat decreases PPAR activity and stability via activation of an ERK-dependent noncanonical pathway, resulting in impaired insulin action. Inhibition of Shh may serve as a potential therapeutic approach to treat obesity-related diabetes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据